Psoriasis - San Diego CA (Clinical Trial # 34134)
Metro Boston Clinical Partners | Studies | Psoriasis
Plaque psoriasis trial; Immunovant's IMVT-1401; Canon's MRI AI programs
Analyzing Psoriasis Clinical Trial Samples | Figure 1
New psoriasis drug effective for three-quarters of patients in clinical trial - UPI.com
Plaque Psoriasis (PsO) Clinical Trials | Enbrel® (etanercept)
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2022
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial - The Lancet
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, H2, 2021
Bimekizumab versus Adalimumab in Plaque Psoriasis | NEJM
Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis - Journal of Dermatological Science
Learn About Our Pediatric Chronic Plaque Psoriasis Clinical Research Study | Arlington Dermatology
Key clinical-trial evidence for risankizumab | DermNet
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis | NEJM
Patient enrollment completed for Dermavant phase 3 psoriasis clinical trials
Data from the Otezla ESTEEM Clinical Trial | Otezla® (apremilast) Healthcare Professional Site
Pediatric Plaque Psoriasis - Santa Ana CA (Clinical Trial # 39805)
Studies | Plaque Psoriasis – Indiana Clinical
Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors - European Medical Journal
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials - Journal of the American Academy of Dermatology
Clinical efficacy of biologic treatments for plaque psoriasis in... | Download Table
Long-term Efficacy and Safety of Tildrakizumab: 5-year Results from the reSURFACE 1 and 2 Phase III Trials in Patients with Moderate-to-severe Plaque Psoriasis - European Medical Journal
